Company
United StatesPublic company, NASDAQ: GRALGrail, Inc (NASDAQ: GRAL), Durham, NC – FDA Inspections
Inspection records and compliance data for Grail, Inc in Durham, NC. 1 FDA inspection on record, last inspected July 16, 2026. Publicly traded as NASDAQ: GRAL.
Company Profile
This profile covers Grail, Inc based in Durham, NC, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected July 16, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 16, 2026 | Not classified | Medical Devices & Rad Health | 1329190 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Duke Raleigh Hospital
CarolinaEast Diagnostic Center
Delaney Radiologists Group
Sentara Albemarle Medical Center
Raleigh GYN/Wellness
Easstern Carolina Women's Center (MQSA)
Atrium Health-Cabarrus Breast Health Center
Ashe Memorial Hospital
Mission Breast Center - Biltmore Park
Greene Co. Health Care - Snow Hill Medical Center
Company Information
Name
Grail, Inc
Stock ticker
GRAL
Exchange
NASDAQ
Share price
$120.49
Market cap
$5.4B
Price as of
November 6, 2026
FEI Number
3026246217
Address
4001 E Nc 54 Hwy Assembly Suite 1100, Research Triangle Park, Durham, NC 27709, United States
Country
United States
ID: 8ba0a113-aeb9-4680-bc5b-ba217fb69902